FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023007598> ?p ?o ?g. }

• W2023007598 endingPage "801" @default.
• W2023007598 startingPage "795" @default.
• W2023007598 abstract "Human aldo-keto reductase AKR1C3 (type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase) catalyzes the reduction of Δ4-androstene-3,17-dione to yield testosterone, the reduction of 5α-dihydrotestosterone to yield 3α- and 3β-androstanediol, and the reduction of estrone to yield 17β-estradiol. Relatively, high mRNA expression of AKR1C3 was found in human prostate and mammary gland where it is implicated in regulating ligand access to the androgen and estrogen receptor, respectively. AKR1C3 shares high sequence identity >86% with related plastic human 20α-hydroxysteroid dehydrogenases (AKR1C1), type 3 3α-hydroxysteroid dehydrogenase (AKR1C2) and type 1 3α-hydroxysteroid dehydrogenase (AKR1C4), and reagents are urgently needed to discriminate between these enzymes at the mRNA, protein and functional level. We describe the characterization of a high-titer isoform specific monoclonal antibody (Ab) for AKR1C3. It does not cross react with human AKR1C1, AKR1C2 or AKR1C4, human aldehyde reductase AKR1A1 or rat 3α-hydroxysteroid dehydrogenase (AKR1C9) on immunoblot analysis. The monoclonal Ab can be used to detect AKR1C3 expression by immunohistochemistry in sections of paraffin-embedded mammary gland and prostate. In the breast enzyme staining was detected in ductal carcinoma in situ where the cancerous cells were strongly immunoreactive. In normal prostate immunoreactivity was limited to stromal cells with only faint staining in the epithelial cells. In adenocarcinoma of the prostate elevated staining was observed in the endothelial cells and carcinoma cells. The reagent thus has utility to access the localized expression of AKR1C3 in hormonal dependent malignancies of the breast and prostate." @default.
• W2023007598 created "2016-06-24" @default.
• W2023007598 creator A5001936860 @default.
• W2023007598 creator A5008562682 @default.
• W2023007598 creator A5047721884 @default.
• W2023007598 creator A5059737908 @default.
• W2023007598 creator A5090216756 @default.
• W2023007598 date "2004-12-01" @default.
• W2023007598 modified "2023-10-01" @default.
• W2023007598 title "Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate" @default.
• W2023007598 cites W137003654 @default.
• W2023007598 cites W1598526550 @default.
• W2023007598 cites W1770562442 @default.
• W2023007598 cites W1984253132 @default.
• W2023007598 cites W2032925662 @default.
• W2023007598 cites W2045040068 @default.
• W2023007598 cites W2066196881 @default.
• W2023007598 cites W2068470211 @default.
• W2023007598 cites W2074169649 @default.
• W2023007598 cites W2081922333 @default.
• W2023007598 cites W2088193717 @default.
• W2023007598 cites W2127529986 @default.
• W2023007598 cites W2130690545 @default.
• W2023007598 cites W2158795471 @default.
• W2023007598 cites W2162536302 @default.
• W2023007598 cites W2164373167 @default.
• W2023007598 cites W4233093525 @default.
• W2023007598 cites W4235684685 @default.
• W2023007598 cites W4250779219 @default.
• W2023007598 doi "https://doi.org/10.1016/j.steroids.2004.09.014" @default.
• W2023007598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15582534" @default.
• W2023007598 hasPublicationYear "2004" @default.
• W2023007598 type Work @default.
• W2023007598 sameAs 2023007598 @default.
• W2023007598 citedByCount "109" @default.
• W2023007598 countsByYear W20230075982012 @default.
• W2023007598 countsByYear W20230075982013 @default.
• W2023007598 countsByYear W20230075982014 @default.
• W2023007598 countsByYear W20230075982015 @default.
• W2023007598 countsByYear W20230075982016 @default.
• W2023007598 countsByYear W20230075982017 @default.
• W2023007598 countsByYear W20230075982018 @default.
• W2023007598 countsByYear W20230075982019 @default.
• W2023007598 countsByYear W20230075982020 @default.
• W2023007598 countsByYear W20230075982021 @default.
• W2023007598 countsByYear W20230075982022 @default.
• W2023007598 countsByYear W20230075982023 @default.
• W2023007598 crossrefType "journal-article" @default.
• W2023007598 hasAuthorship W2023007598A5001936860 @default.
• W2023007598 hasAuthorship W2023007598A5008562682 @default.
• W2023007598 hasAuthorship W2023007598A5047721884 @default.
• W2023007598 hasAuthorship W2023007598A5059737908 @default.
• W2023007598 hasAuthorship W2023007598A5090216756 @default.
• W2023007598 hasConcept C121608353 @default.
• W2023007598 hasConcept C126322002 @default.
• W2023007598 hasConcept C134018914 @default.
• W2023007598 hasConcept C134651460 @default.
• W2023007598 hasConcept C153911025 @default.
• W2023007598 hasConcept C159654299 @default.
• W2023007598 hasConcept C181199279 @default.
• W2023007598 hasConcept C203014093 @default.
• W2023007598 hasConcept C204232928 @default.
• W2023007598 hasConcept C2776235491 @default.
• W2023007598 hasConcept C2776317432 @default.
• W2023007598 hasConcept C2777486698 @default.
• W2023007598 hasConcept C2777911890 @default.
• W2023007598 hasConcept C2778683662 @default.
• W2023007598 hasConcept C2779279991 @default.
• W2023007598 hasConcept C2781067048 @default.
• W2023007598 hasConcept C542903549 @default.
• W2023007598 hasConcept C54355233 @default.
• W2023007598 hasConcept C55493867 @default.
• W2023007598 hasConcept C71315377 @default.
• W2023007598 hasConcept C71924100 @default.
• W2023007598 hasConcept C86803240 @default.
• W2023007598 hasConceptScore W2023007598C121608353 @default.
• W2023007598 hasConceptScore W2023007598C126322002 @default.
• W2023007598 hasConceptScore W2023007598C134018914 @default.
• W2023007598 hasConceptScore W2023007598C134651460 @default.
• W2023007598 hasConceptScore W2023007598C153911025 @default.
• W2023007598 hasConceptScore W2023007598C159654299 @default.
• W2023007598 hasConceptScore W2023007598C181199279 @default.
• W2023007598 hasConceptScore W2023007598C203014093 @default.
• W2023007598 hasConceptScore W2023007598C204232928 @default.
• W2023007598 hasConceptScore W2023007598C2776235491 @default.
• W2023007598 hasConceptScore W2023007598C2776317432 @default.
• W2023007598 hasConceptScore W2023007598C2777486698 @default.
• W2023007598 hasConceptScore W2023007598C2777911890 @default.
• W2023007598 hasConceptScore W2023007598C2778683662 @default.
• W2023007598 hasConceptScore W2023007598C2779279991 @default.
• W2023007598 hasConceptScore W2023007598C2781067048 @default.
• W2023007598 hasConceptScore W2023007598C542903549 @default.
• W2023007598 hasConceptScore W2023007598C54355233 @default.
• W2023007598 hasConceptScore W2023007598C55493867 @default.
• W2023007598 hasConceptScore W2023007598C71315377 @default.
• W2023007598 hasConceptScore W2023007598C71924100 @default.
• W2023007598 hasConceptScore W2023007598C86803240 @default.
• W2023007598 hasIssue "13-14" @default.

• next